TOPGEN

company

About

TOPGEN provides tumor-oriented precision medical testing, cellular immunotherapy, and other services.

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
¥120M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2012
Number Of Employee
51 - 100
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥145M
TOPGEN has raised a total of ¥145M in funding over 2 rounds. Their latest funding was raised on Jul 13, 2020 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 13, 2020 Series C ¥120M 3 Detail
Mar 16, 2017 Post-IPO Equity ¥25M 1 Detail

Investors

Number of Lead Investors
Number of Investors
4
TOPGEN is funded by 4 investors. Zhujijingkaichuangrong Touzi and Zhuji Jingkai Chuangyou Guquan Jijin are the most recent investors.
Investor Name Lead Investor Funding Round
Zhujijingkaichuangrong Touzi Series C
Zhuji Jingkai Chuangyou Guquan Jijin Series C
Shanghai Hantai Chuangye Touzi Series C
Guoke Zhengdao Investment Post-IPO Equity